Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study - Tanaka, Yoshiya; Kondo, Kazuoki; Ichibori, Ayako; Yanai, Yoshiari; Susuta, Yutaka; Inoue, Shinsuke; Takeuchi, Tsutomu (Lupus, 2020)
Keywords: Adult; Autoantibodies; Cell number; Double-Blind Method; Female; Humans; Lupus; Lupus Erythematosus, Systemic; Lymphocytes; Male; Middle Aged; Non-Randomized Controlled Trials as Topic; Peripheral blood; Pharmacodynamics; Pharmacokinetics; Propanolamines; Sphingosine 1-phosphate; Sphingosine-1-Phosphate Receptors; Systemic lupus erythematosus; lymphocyte subsets; lymphocyte count; Systemic lupus erythematosus; anti-ds-DNA antibody; S1P modulator; amiselimod